Pathogenic mechanisms in pulmonary fibrosis. Collagen induced migration inhibition factor production and cytotoxicity mediated by lymphocytes

T. C. Kravis, A. Ahmed, T. E. Brown, J. D. Fulmer, Ronald Crystal

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

The universal features of the histopathology of fibrotic lung disease are derangement of parenchymal collagen and infiltration of the parenchyma with chronic inflammatory cells. To determine if this cellular reaction might be associated with autoimmunity to a constituent of the alveolar interstitium, peripheral blood lymphocytes were exposed to human type I collagen in vitro and evaluated for the production of migration inhibition factor and cytotoxicity. Data from 18 patients with idiopathic pulmonary fibrosis, 8 patients with pulmonary fibrosis other than idiopathic pulmonary fibrosis, 12 patients with nonfibrotic lung disease, and 9 normals demonstrated that circulating lymphocytes from more than 94% of patients with fibrotic lung disease take part in processes where the recognition of collagen results in migration inhibition factor production and lysis of collagen coated sheep red blood cells. These collagen induced cell mediated phenomena are obviated with human T lymphocyte antiserum. Collagen induced migration inhibition factor production and cytotoxicity were found in less than 20% of patients with nonfibrotic disease and were not found in normals. Qualitatively, there was no organ (lung, skin) or species (human, rabbit) collagen specificity in these assays, but human lung α2 chains were recognized more often than α1(I) chains. Circulating lymphocytes from patients with fibrotic disease are present in a normal T to B ratio. These lymphocytes did not incorporate [3H]thymidine when exposed to collagen but did when exposed to T cell mitogens. These in vitro observations suggest that circulating T lymphocytes and lung collagen may be intimately associated in the pathogenesis of human fibrotic lung disease.

Original languageEnglish
Pages (from-to)1223-1232
Number of pages10
JournalUnknown Journal
Volume58
Issue number5
DOIs
Publication statusPublished - 1 Jan 1976
Externally publishedYes

Fingerprint

Pulmonary Fibrosis
collagen
Collagen
Lymphocytes
Lung Diseases
Idiopathic Pulmonary Fibrosis
T-Lymphocytes
Lung
blood
cytotoxicity
histopathology
Collagen Type I
Autoimmunity
Mitogens
lysis
Thymidine
Immune Sera
sheep
Sheep
Erythrocytes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pathogenic mechanisms in pulmonary fibrosis. Collagen induced migration inhibition factor production and cytotoxicity mediated by lymphocytes. / Kravis, T. C.; Ahmed, A.; Brown, T. E.; Fulmer, J. D.; Crystal, Ronald.

In: Unknown Journal, Vol. 58, No. 5, 01.01.1976, p. 1223-1232.

Research output: Contribution to journalArticle

@article{c4f9e6695e3c4fd4a32ae7ea88fe0925,
title = "Pathogenic mechanisms in pulmonary fibrosis. Collagen induced migration inhibition factor production and cytotoxicity mediated by lymphocytes",
abstract = "The universal features of the histopathology of fibrotic lung disease are derangement of parenchymal collagen and infiltration of the parenchyma with chronic inflammatory cells. To determine if this cellular reaction might be associated with autoimmunity to a constituent of the alveolar interstitium, peripheral blood lymphocytes were exposed to human type I collagen in vitro and evaluated for the production of migration inhibition factor and cytotoxicity. Data from 18 patients with idiopathic pulmonary fibrosis, 8 patients with pulmonary fibrosis other than idiopathic pulmonary fibrosis, 12 patients with nonfibrotic lung disease, and 9 normals demonstrated that circulating lymphocytes from more than 94{\%} of patients with fibrotic lung disease take part in processes where the recognition of collagen results in migration inhibition factor production and lysis of collagen coated sheep red blood cells. These collagen induced cell mediated phenomena are obviated with human T lymphocyte antiserum. Collagen induced migration inhibition factor production and cytotoxicity were found in less than 20{\%} of patients with nonfibrotic disease and were not found in normals. Qualitatively, there was no organ (lung, skin) or species (human, rabbit) collagen specificity in these assays, but human lung α2 chains were recognized more often than α1(I) chains. Circulating lymphocytes from patients with fibrotic disease are present in a normal T to B ratio. These lymphocytes did not incorporate [3H]thymidine when exposed to collagen but did when exposed to T cell mitogens. These in vitro observations suggest that circulating T lymphocytes and lung collagen may be intimately associated in the pathogenesis of human fibrotic lung disease.",
author = "Kravis, {T. C.} and A. Ahmed and Brown, {T. E.} and Fulmer, {J. D.} and Ronald Crystal",
year = "1976",
month = "1",
day = "1",
doi = "10.1172/JCI108576",
language = "English",
volume = "58",
pages = "1223--1232",
journal = "JAPCA",
issn = "1073-161X",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

TY - JOUR

T1 - Pathogenic mechanisms in pulmonary fibrosis. Collagen induced migration inhibition factor production and cytotoxicity mediated by lymphocytes

AU - Kravis, T. C.

AU - Ahmed, A.

AU - Brown, T. E.

AU - Fulmer, J. D.

AU - Crystal, Ronald

PY - 1976/1/1

Y1 - 1976/1/1

N2 - The universal features of the histopathology of fibrotic lung disease are derangement of parenchymal collagen and infiltration of the parenchyma with chronic inflammatory cells. To determine if this cellular reaction might be associated with autoimmunity to a constituent of the alveolar interstitium, peripheral blood lymphocytes were exposed to human type I collagen in vitro and evaluated for the production of migration inhibition factor and cytotoxicity. Data from 18 patients with idiopathic pulmonary fibrosis, 8 patients with pulmonary fibrosis other than idiopathic pulmonary fibrosis, 12 patients with nonfibrotic lung disease, and 9 normals demonstrated that circulating lymphocytes from more than 94% of patients with fibrotic lung disease take part in processes where the recognition of collagen results in migration inhibition factor production and lysis of collagen coated sheep red blood cells. These collagen induced cell mediated phenomena are obviated with human T lymphocyte antiserum. Collagen induced migration inhibition factor production and cytotoxicity were found in less than 20% of patients with nonfibrotic disease and were not found in normals. Qualitatively, there was no organ (lung, skin) or species (human, rabbit) collagen specificity in these assays, but human lung α2 chains were recognized more often than α1(I) chains. Circulating lymphocytes from patients with fibrotic disease are present in a normal T to B ratio. These lymphocytes did not incorporate [3H]thymidine when exposed to collagen but did when exposed to T cell mitogens. These in vitro observations suggest that circulating T lymphocytes and lung collagen may be intimately associated in the pathogenesis of human fibrotic lung disease.

AB - The universal features of the histopathology of fibrotic lung disease are derangement of parenchymal collagen and infiltration of the parenchyma with chronic inflammatory cells. To determine if this cellular reaction might be associated with autoimmunity to a constituent of the alveolar interstitium, peripheral blood lymphocytes were exposed to human type I collagen in vitro and evaluated for the production of migration inhibition factor and cytotoxicity. Data from 18 patients with idiopathic pulmonary fibrosis, 8 patients with pulmonary fibrosis other than idiopathic pulmonary fibrosis, 12 patients with nonfibrotic lung disease, and 9 normals demonstrated that circulating lymphocytes from more than 94% of patients with fibrotic lung disease take part in processes where the recognition of collagen results in migration inhibition factor production and lysis of collagen coated sheep red blood cells. These collagen induced cell mediated phenomena are obviated with human T lymphocyte antiserum. Collagen induced migration inhibition factor production and cytotoxicity were found in less than 20% of patients with nonfibrotic disease and were not found in normals. Qualitatively, there was no organ (lung, skin) or species (human, rabbit) collagen specificity in these assays, but human lung α2 chains were recognized more often than α1(I) chains. Circulating lymphocytes from patients with fibrotic disease are present in a normal T to B ratio. These lymphocytes did not incorporate [3H]thymidine when exposed to collagen but did when exposed to T cell mitogens. These in vitro observations suggest that circulating T lymphocytes and lung collagen may be intimately associated in the pathogenesis of human fibrotic lung disease.

UR - http://www.scopus.com/inward/record.url?scp=0017108831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017108831&partnerID=8YFLogxK

U2 - 10.1172/JCI108576

DO - 10.1172/JCI108576

M3 - Article

VL - 58

SP - 1223

EP - 1232

JO - JAPCA

JF - JAPCA

SN - 1073-161X

IS - 5

ER -